| Metric | სს გეფა | შპს SmartPharm |
|---|---|---|
| Growth | ||
| Revenue | ₾861.8m₾823.7m | ₾36.6m₾31.6m |
| Revenue growth | 4.6% | 15.9% |
| Profitability | ||
| EBITDA | ₾122.4m₾107.6m | ₾2.0m₾3.3m |
| EBITDA margin | 14.2%13.1% | 5.4%10.4% |
| Net profit | ₾51.8m₾60.1m | ₾1.9m₾2.8m |
| Net margin | 6.0%7.3% | 5.2%8.8% |
| Balance sheet | ||
| Total assets | ₾554.9m₾597.2m | ₾16.6m₾13.4m |
| Total equity | ₾201.4m₾197.3m | ₾13.1m₾11.6m |
| ROE | 25.7%30.4% | 14.5%23.9% |